Unlock instant, AI-driven research and patent intelligence for your innovation.

Bovine viral diarrhea virus recombinant subunit vaccine

A technology for bovine viral diarrhea and viruses, which is applied in the field of human vaccines and human biological products, can solve the problems of large differences in virulence, low titer, and cattle infection, and achieve batch-to-batch stability and strong immunogenicity , the effect of high expression level

Active Publication Date: 2020-10-16
苏州世诺生物技术有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Because BVDV has different biotypes, different genotypes, and the virulence of different strains varies greatly, most attenuated or avirulent BVDV type II strains may cause persistent infection in cattle. The current traditional BVDV vaccine Only BVDV type I is included, for example, CN105949286A discloses a method for expressing type I BVDV E2 protein alone
Moreover, studies have shown that the nucleotide homology between BVDV type Ⅰ and BVDV type Ⅱ E2 proteins is less than 60%, and the amino acid homology is lower than 65%. There are also two amino acid residues missing in the BVDV type Ⅱ E2 protein. A deletion leads to different antigenic epitopes between BVDV type Ⅱ and BVDV type Ⅰ, indicating that BVDV type Ⅰ vaccine has no effective protective effect against BVDV II infection
CN107823639A discloses a whole virus inactivated vaccine prepared from four genotype inactivated antigens of BVDV Ia, BVDV Ib, BVDVIIa, and BVDVIIb. Although the vaccine has a high degree of safety, there are still problems such as low titer, high risk of spreading the virus, and low matching degree with popular strains

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bovine viral diarrhea virus recombinant subunit vaccine
  • Bovine viral diarrhea virus recombinant subunit vaccine
  • Bovine viral diarrhea virus recombinant subunit vaccine

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0038] An aspect of the embodiments of the present invention also provides a method for preparing a recombinant bovine viral diarrhea virus fusion protein, comprising:

[0039] Cloning of a eukaryotic expression vector comprising a recombinant bovine viral diarrhea virus fusion protein encoding gene;

[0040] Transfect CHO cells with the eukaryotic expression vector, and screen to obtain a CHO cell strain capable of stably and efficiently expressing the recombinant bovine viral diarrhea virus fusion protein in suspension, then ferment and culture the CHO cell strain, and then separate to obtain the recombinant Bovine viral diarrhea virus fusion protein;

[0041] The fusion protein has the amino acid sequence shown in SEQ ID NO:2 or an amino acid sequence more than 95% identical to the full-length amino acid sequence of SEQ ID NO:2.

[0042] In some embodiments, the eukaryotic expression vector includes but is not limited to pSV2-GS, pCI-GS or pcDNA4-GS, etc., preferably pCI-G...

Embodiment 1

[0065] Embodiment 1 Construction of recombinant eukaryotic expression vector pCI-Fu-GS

[0066] 1. Amplification and purification of BVDV-Fu gene The codon-optimized BVDV-Fu gene (SEQ ID NO: 1) was synthesized in Nanjing GenScript Biotechnology Co., Ltd. and cloned into the pUC-57 vector. For Kpn Ⅰ and Xho Ⅰ, the pUC-Fu plasmid vector was obtained. Use pUC-Fu as a template, and Fu-F and Fu-R as primers for PCR amplification (the gene sequences of Fu-F and Fu-R are shown in SEQ ID NO: 3 and SEQ ID NO: 4), and the amplification system See Table 1. The reaction conditions were: pre-denaturation at 94°C for 5 minutes; denaturation at 95°C for 45 seconds, renaturation at 60°C for 45 seconds, extension at 72°C for 2 minutes, 30 cycles; extension at 72°C for 10 minutes, and storage at 4°C.

[0067] Table 1 BVDV-Fu gene amplification system

[0068]

[0069] Perform gel electrophoresis on the PCR product to identify the size of the target gene, such as figure 1 As shown, a band...

Embodiment 2

[0080] Example 2 Construction and Screening of Recombinant CHO Cells Expressing BVDV-Fu Protein

[0081] 1. Cell Transfection

[0082] 1.1 Prepare cells Take CHO cells in the logarithmic growth phase, sample and count, and use 1×10 6 The cell density of cells / ml continued to be subcultured, the seeds were maintained, and the remaining cells were centrifuged at 1000 rpm for 4 minutes, then the supernatant was discarded, resuspended with about 20 ml of fresh CHO-WM medium, centrifuged again, and centrifuged at 1000 rpm for 4 minutes. Discard the supernatant and resuspend with a small amount of medium for counting, and finally adjust the cell density to 1.43×10 7 cells / ml.

[0083] 1.2 Plasmid and cell mixing Take 5 μg of the pCI-Fu-GS carrier obtained in Example 1, add it to the EP tube, add 0.7ml cells, mix well, and let stand for 15 minutes.

[0084] 1.3 Electroporation 280V 20 ms electric shock for 2 pulses. Immediately after the electric shock was completed, the cells wer...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a recombinant subunit vaccine of bovine viral diarrhea virus, which comprises recombinant bovine viral diarrhea virus fusion protein (BVDV‑Fu) as an active ingredient, and the amino acid sequence of the fusion protein is shown in SEQ ID NO: 2 Show. The vaccine of the invention can produce strong humoral immunity in cattle, and the immunized cattle can resist the attack of strong viruses, and the vaccine of the invention can be produced industrially on a large scale, with low cost, stable quality and high safety.

Description

technical field [0001] The invention relates to a genetic engineering vaccine, in particular to a bovine viral diarrhea virus recombinant subunit vaccine, its preparation method and application, and belongs to the field of human vaccines and human biological products. Background technique [0002] Bovine viral diarrhea (BVD) is an acute, contagious disease caused by bovine viral diarrhea virus (BVDV). In addition to infecting cattle, BVDV can also infect pigs, deer, sheep, camels and other wild animals, and there are even reports of infecting humans, with a wide range of hosts. The disease is mainly characterized by erosion of digestive tract mucosa, fever, cough, diarrhea, and abortion or malformed fetuses of pregnant cows. Once infected, it can cause persistent infection. When the persistently infected cattle are in a state of immune tolerance, they do not show any symptoms clinically, but they are still infected and detoxified, which can seriously damage the immune funct...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N15/85C12N5/10A61K39/12A61P31/14
CPCA61K39/12A61K2039/552A61P31/14C07K14/005C07K2319/00C12N15/85C12N2770/24322C12N2770/24334
Inventor 曹文龙孔迪滕小锘易小萍张大鹤
Owner 苏州世诺生物技术有限公司